{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:40:24Z","timestamp":1791751224700,"version":"4.3.4"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Optimal duration of antibiotic therapy in Gram-negative bacterial (GNB) sepsis in non-VLBW infants has not been specifically evaluated in previous studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This was an open labeled noninferiority randomized controlled trial. Non-VLBW infants with GNB sepsis without meningitis whose blood culture were sterile after day 7 of treatment and who were in clinical remission on day 9 of appropriate antibiotic were randomized to short duration (SDR) group and long duration (LDR) group. Infants in SDR group and LDR group received antibiotic therapy for 10 days and 14 days respectively. Primary objective was to compare treatment failure. Secondary objectives were to compare duration of hospitalization, complications of intravenous (IV) therapy and its duration, episodes of new-onset sepsis and all-cause mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 222 infants with GNB sepsis, 58 eligible infants were randomized in each group and 113 of these were analyzed. There was no difference in proportion of infants with multidrug-resistant (MDR) organism in SDR versus LDR group [33(60%) versus 32(55.1%) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.84)]. There were no treatment failures in either group. Median (IQR) duration of hospital stay was higher in LDR group as compared with SDR group: 20(18, 23) versus 16(13, 20) days (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.001). Infants in LDR group required IV therapy for a longer duration as compared with SDR group mean (SD): 15.2(1.2) versus 10.9(0.8) days (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.001). Median (IQR) episodes of extravasation were higher in LDR group: 5(4.7) versus 3(2.3) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.001). There was no difference in episodes of phlebitis and hematoma. No infants had died on follow up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In suitably selected non-VLBW infants with Gram-negative sepsis, 10 days therapy is noninferior to 14 days therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003314","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T19:16:27Z","timestamp":1639163787000},"page":"156-160","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Duration of Antibiotic Therapy in Neonatal Gram-negative Bacterial Sepsis\u201410 Days Versus 14 Days"],"prefix":"10.1097","volume":"41","author":[{"given":"Anurag","family":"Fursule","sequence":"first","affiliation":[{"name":"From the Department of Neonatology, Institute of Child Health, Sir Ganga Ram Hospital, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Thakur","sequence":"additional","affiliation":[{"name":"From the Department of Neonatology, Institute of Child Health, Sir Ganga Ram Hospital, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Garg","sequence":"additional","affiliation":[{"name":"From the Department of Neonatology, Institute of Child Health, Sir Ganga Ram Hospital, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Kler","sequence":"additional","affiliation":[{"name":"From the Department of Neonatology, Institute of Child Health, Sir Ganga Ram Hospital, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ajic.2006.06.013","article-title":"A 10-year prospective surveillance of nosocomial infections in neonatal intensive care units.","volume":"35","author":"Couto","year":"2007","journal-title":"Am J Infect Control"},{"issue":"2 pt 1","key":"R3-20250615","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1542\/peds.110.2.285","article-title":"Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network.","volume":"110","author":"Stoll","year":"2002","journal-title":"Pediatrics"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12098-010-0005-5","article-title":"Nosocomial infections in neonatal intensive care units: profile, risk factor assessment and antibiogram.","volume":"77","author":"Kamath","year":"2010","journal-title":"Indian J Pediatr"},{"key":"R5-20250615","first-page":"168","article-title":"Nosocomial bloodstream infection in a neonatal intensive care unit of a medical center: a three-year review.","volume":"35","author":"Tseng","year":"2002","journal-title":"J Microbiol Immunol Infect"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijid.2008.08.020","article-title":"Etiology of neonatal blood stream infections in Tbilisi, Republic of Georgia.","volume":"13","author":"Macharashvili","year":"2009","journal-title":"Int J Infect Dis"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1016\/S2214-109X(16)30148-6","article-title":"Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study.","volume":"4","year":"2016","journal-title":"Lancet Glob Heal"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/jama.279.5.394","article-title":"Strategies for stemming the tide of antimicrobial resistance.","volume":"279","author":"Low","year":"1998","journal-title":"JAMA"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"k5314","DOI":"10.1136\/bmj.k5314","article-title":"Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance.","volume":"364","author":"Chaurasia","year":"2019","journal-title":"BMJ"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/tropej\/fmq012","article-title":"Ten days vs. 14 days antibiotic therapy in culture-proven neonatal sepsis.","volume":"56","author":"Gathwala","year":"2010","journal-title":"J Trop Pediatr"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/tropej\/fml054","article-title":"Randomized controlled trial of 7-day vs. 14-day antibiotics for neonatal sepsis.","volume":"52","author":"Chowdhary","year":"2006","journal-title":"J Trop Pediatr"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/jpc.13518","article-title":"Seven versus 10 days antibiotic therapy for culture-proven neonatal sepsis: a randomised controlled trial.","volume":"53","author":"Rohatgi","year":"2017","journal-title":"J Paediatr Child Health"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jhin.2003.12.038","article-title":"Development of a surveillance system for nosocomial infections: the component for neonatal intensive care units in Germany.","volume":"57","author":"Gastmeier","year":"2004","journal-title":"J Hosp Infect"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"246","DOI":"10.21037\/tp.2019.07.03","article-title":"Economic assessment of neonatal intensive care.","volume":"8","author":"Cheah","year":"2019","journal-title":"Transl Pediatr"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02760575","article-title":"NICU in a community level hospital.","volume":"72","author":"Garg","year":"2005","journal-title":"Indian J Pediatr"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s13312-013-0234-6","article-title":"Cost of neonatal intensive care delivered through district level public hospitals in India.","volume":"50","author":"Prinja","year":"2013","journal-title":"Indian Pediatr"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s13312-016-0933-x","article-title":"Cost analysis of healthcare in a private sector neonatal intensive care unit in India.","volume":"53","author":"Karambelkar","year":"2016","journal-title":"Indian Pediatr"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/sim.2584","article-title":"Committee for Medicinal Products for Human Use (CHMP) guideline on the choice of the non-inferiority margin.","volume":"25","year":"2006","journal-title":"Stat Med"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3345\/kjp.2012.55.11.403","article-title":"Understanding noninferiority trials.","volume":"55","author":"Hahn","year":"2012","journal-title":"Korean J Pediatr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:02:52Z","timestamp":1750003372000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003314"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003314","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,9]]}}}